secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001367644-24-000053
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions awards $1.45M in additional retention bonuses to four top executives
--------------------------------------------------------------------------------

- CFO Richard Lindahl receives $399,753; GC Jennifer Fox $380,250; EVP Quality Coleen Glessner $373,761; SVP Products Paul Williams $292,501.
- Bonuses payable by Dec 31, 2024, subject to continued employment; acceleration possible upon transaction support agreement with debt holders.
- Clawback: executives must repay bonuses if they voluntarily leave or are terminated for cause before retention period ends.
- Retention period ends earlier of July 26, 2024 (initial bonuses), Dec 31, 2024 (additional), or 30 days after change of control or bankruptcy exit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000053/0001367644-24-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000053/ebs-20240423.htm
  HTML page:      https://secwatch.observer/filing/0001367644-24-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer